Cargando…
Longitudinal exploration of cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma: protocol for a feasibility study
INTRODUCTION: Cancer-related cognitive impairment (CRCI) is a distressing and disabling side-effect of cancer treatments affecting up to 75% of patients. For some patients, their cognitive impairment may be transient, but for a subgroup, these symptoms can be long-standing and have a major impact on...
Autores principales: | Gates, Priscilla, Gough, Karla, Dhillon, Haryana, Wilson, Carlene, Hawkes, Eliza, Dore, Vincent, Perchyonok, Yuliya, Rowe, Christopher C, Walker, Adam K, Vardy, Janette L, de Ruiter, Michiel, Krishnasamy, Meinir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526311/ https://www.ncbi.nlm.nih.gov/pubmed/32994248 http://dx.doi.org/10.1136/bmjopen-2020-038312 |
Ejemplares similares
-
Cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma undergoing standard chemotherapy: a longitudinal feasibility study
por: Gates, Priscilla, et al.
Publicado: (2022) -
SWIM (sickle with ibuprofen and morphine) randomised controlled trial fails to recruit: lessons learnt
por: Cho, Gavin, et al.
Publicado: (2016) -
Adaptation of the PERCEPT myeloma prehabilitation trial to virtual delivery: changes in response to the COVID-19 pandemic
por: McCourt, Orla, et al.
Publicado: (2022) -
Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study
por: Schütte, Lisette M, et al.
Publicado: (2019) -
Exploration of motivation to participate in a study of cancer-related cognitive impairment among patients with newly diagnosed aggressive lymphoma: a qualitative sub-study
por: Gates, Priscilla, et al.
Publicado: (2021)